PlanVest Financial’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
PlanVest Financial's LPCN Position: Q3 2026 in Review
PlanVest Financial held its Lipocine (LPCN) position steady in Q3 2026 at 111 shares worth $244. The position accounts for ﹤0.01% of the portfolio, ranked #580.
PlanVest Financial first reported a position in LPCN in Q1 2026 and has held it in 3 quarters since. The position peaked at $887 in Q1 2026. 38 funds tracked by Wall St. Rank hold LPCN as of Q3 2026.
- PlanVest Financial held 111 shares of Lipocine worth $244 as of Q3 2026.
- PlanVest Financial left its Lipocine share count unchanged in Q3 2026.
- Lipocine made up ﹤0.01% of PlanVest Financial's portfolio in Q3 2026, its #580 holding.
- PlanVest Financial first reported a position in Lipocine in Q1 2026 and has held it in 3 quarters since.
- PlanVest Financial's Lipocine position peaked at $887 in Q1 2026.
- 38 funds tracked by Wall St. Rank held Lipocine as of Q3 2026.
Based on PlanVest Financial's 13F filing for Q3 2026, filed 9 Nov 2026.